By outfitting patients with continuous heart monitors, providers might be able to catch atrial fibrillation that they wouldn’t find in clinical settings, according to a new study in JAMA. Researchers could also use the monitors for clinical trials.
Wearable heart monitors reveal otherwise undetected atrial fibrillation
